Faeth Therapeutics’ $47 Million Series A Financing

Wilson Sonsini advised Faeth Therapeutics on the deal.Faeth Therapeutics, a cancer metabolism company, announced the completion of a Series A financing of $47 million led by…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here